New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For MDT;COV;INTC;BSX;VRTX;JNJ From The Last 14 Days
Check below for free stories on MDT;COV;INTC;BSX;VRTX;JNJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
July 22, 2014
08:25 EDTBSXBoston Scientific risk/reward favorable into Q2 results, says RBC Capital
Subscribe for More Information
07:07 EDTCOVCovidien names Bryan Hanson as group president, effective October 1
Subscribe for More Information
05:59 EDTINTCStocks with implied volatility below IV index mean; INTC SHPG
Subscribe for More Information
July 21, 2014
18:40 EDTJNJOn The Fly: After Hours Movers
UP AFTER EARNINGS: Netflix (NFLX), up marginally after reporting Q2 results... Sanmina (SANM), up 13.2% after reporting third quarter results and fourth quarter guidance above analyst estimates... Chipotle (CMG), up 10.1%... Helix (HLX), up 5.2%... Canadian National (CNI), up 1.13%... CYS Investments (CYS), up 1.7%. ALSO HIGHER: Apache (APA), up 5% after Bloomberg says JANA discloses $1B position... Johnson & Johnson (JNJ), up 1% after announcing a $5B share repurchase program... TG Therapeutics (TGTX), up 4.3% after reporting second quarter results and preliminary clinical results from TG-1101 Phase I study... DOWN AFTER EARNINGS: Rambus (RMBS), down 3.6% after reporting second quarter results... Ultra Clean (UCTT), down 4% after reporting quarterly results. ALSO LOWER: Tallgrass Energy (TEP), down 5% after filing to sell 7M common units representing limited partners.
17:03 EDTJNJJohnson & Johnson announces $5B share repurchase program
Johnson & Johnson announced that its board has approved the repurchase of up to $5B of the company's common stock. The company had approximately 2.82B shares of common stock outstanding as of June 29.
17:01 EDTJNJJohnson & Johnson announces $5B share repurchase program
16:38 EDTBSXBoston Scientific receives FDA approval for REBEL Platinum Stent system
Subscribe for More Information
12:41 EDTINTCIntel advances after analyst predicts mobile unit rebound coming
Shares of Intel (INTC) are advancing in a down market after Wells Fargo wrote that the company's mobile chip business could rebound significantly in coming quarters. WHAT'S NEW: Intel's mobile chip business could boost the company's growth and even enable it to beat earnings expectations, Wells Fargo wrote in a note to investors today. The chip maker's shipments of 4G modems should start rising significantly in the third quarter or fourth quarter of this year, the firm stated. The company has probably won some deals to provide LTE modems for smartphones and Samsung is likely one of the chip maker's initial customers, the firm wrote. Broadcom's (BRCM) decision to exit the baseband market probably improved Intel's position in the 4G market, Wells Fargo contended. Meanwhile, Intel said that by this year's holiday season, it should be ready to launch chips for mobile devices that are smaller than those of a key competitor, TSMC (TSM), Wells noted. Sales generated by Intel's mobile and communications unit may have bottomed last quarter or could do so during the current quarter, the firm believes. The unit's operating losses are likely to drop throughout this year, before falling sharply in the quarter ended March 2015, Wells estimated. The unit may approach break even by the end of 2015, the firm added. Wells kept an Outperform rating on the stock. WHAT'S NOTABLE: On July 15, Intel reported stronger than expected results for its quarter ended in June. PRICE ACTION: In early afternoon trading, Intel rose 43c, or 1.3%, to $34.13.
08:16 EDTCOV, MDTDeutsche Bank analysts hold an analyst/industry conference call
Subscribe for More Information
07:34 EDTINTCIntel mobile business could be source of growth, says Wells Fargo
Wells Fargo believes that Intel's Mobile & Communications segment could be an important growth and profit driver for the company starting next year. The firm thinks the company's manufacturing technology lead and efforts to establish a foundry business could boost its Mobile & Communications segment. It keeps an Outperform rating on the stock.
07:15 EDTINTCO'Reilly to hold a conference
Subscribe for More Information
06:14 EDTINTCStocks with implied volatility below IV index mean; INTC SHPG
Subscribe for More Information
July 18, 2014
16:47 EDTINTCMarket ends week higher as earnings, M&A offset geopolitical tensions
Subscribe for More Information
12:51 EDTCOV, MDTKey GOP senator signals readiness for inversion deal, The Hill says
Subscribe for More Information
12:36 EDTINTCPlug Power said to be on list of companies probed by SEC, Probes Reporter says
Subscribe for More Information
11:42 EDTINTCAMD plummets after profit miss, analyst downgrades
Subscribe for More Information
11:34 EDTCOVOptions with increasing implied volatility
Subscribe for More Information
06:06 EDTINTCStocks with implied volatility below IV index mean; LULU INTC
Subscribe for More Information
July 17, 2014
18:31 EDTINTCOn The Fly: After Hours Movers
Subscribe for More Information
14:54 EDTJNJJohnson & Johnson weakness creates buying opportunity, says Argus
Subscribe for More Information
11:23 EDTCOVOptions with increasing implied volatility
Subscribe for More Information
10:56 EDTJNJJohnson & Johnson reports 18% passive stake in Minerva
Subscribe for More Information
10:00 EDTCOVOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 21st Century Fox (FOXA) downgraded to Buy from Strong Buy at ISI Group... Charter (CHTR) downgraded to Hold from Buy at Jefferies... Covidien (COV) downgraded to Hold from Buy at Needham... Diageo (DEO) downgraded to Underweight from Neutral at JPMorgan... GNC Holdings (GNC) downgraded to Hold from Buy at Jefferies... International Game (IGT) downgraded to Market Perform from Outperform at BMO Capital... JAVELIN Mortgage (JMI) downgraded to Market Perform from Outperform at JMP Securities... Macquarie Group (MQBKY) downgraded to Underweight from Neutral at JPMorgan... PNC Financial (PNC) downgraded to Neutral from Buy at Compass Point... PetSmart (PETM) downgraded to Sector Perform from Outperform at RBC Capital... Rexam (REXMY) downgraded to Hold from Buy at Deutsche Bank.
09:40 EDTINTCActive equity options trading on open
Subscribe for More Information
07:51 EDTINTCSenate Finance Committee to hold a hearing
The Committee holds a hearing entitled, "The Role of Trade & Technology in 21st Century Manufacturing" with Vice President Sturm of Intel on July 17 at 10 am. Webcast Link
06:41 EDTCOVCovidien downgraded to Hold from Buy at Needham
Subscribe for More Information
05:56 EDTINTCStocks with implied volatility below IV index mean; LULU INTC
Subscribe for More Information
July 16, 2014
17:55 EDTINTCIntel looks like a hold, Barron's says
Subscribe for More Information
16:24 EDTINTCOn The Fly: Closing Wrap
Stocks on Wall Street started the trading day higher, thanks in part to solid earnings reports from some of the nationís largest companies as well as a proposed mega-merger in the entertainment industry. Investors preparing for the next round of earnings after the close, which includes reports from eBay (EBAY), Yum! Brands (YUM), and Las Vegas Sands (LVS), did so with the Dow at a new all-time high. ECONOMIC EVENTS: In the U.S., the Producer Price Index for June rose 0.4%, which was ahead of expectations for a 0.2% increase. Industrial production grew 0.2% in June, missing the forecast for 0.3% growth. The NAHB homebuilder confidence index rose to 53 in July, ahead of expectations for it to tick up 1 point to 50. Economic activity expanded in all regions of the country at a moderate to modest pace in recent weeks, the Fed reported today in its Beige Book. Consumer spending rose in every region, as retail sales grew modestly in most areas and vehicle sales were stronger than sales of most other products, the central bank reported. COMPANY NEWS: Shares of HBO and Warner Bros. parent Time Warner (TWX) surged $12.12, or 17.07%, to $83.13 after it was reported by CNBC and DealBook's Andrew Ross Sorkin that the company had received, and rejected, a takeover offer worth about $80B, or $85 per share, from Rupert Murdoch's Twenty-First Century Fox (FOXA). Both Time Warner and Fox subsequently confirmed the report, with Time Warner stating that it rejected the bid since it was "not in the best interests of stockholders" and Fox noting that the companies are not currently in discussions. Afterward, research firm Jefferies said it believes 21st Century Fox could raise its bid for Time Warner into the mid-to-upper $90's per share, but it also thinks that Time Warner would still be unlikely to accept the offer. Meanwhile, FBR Capital said Fox could pay up to $120 for Time Warner and still make an accretive deal. Class A shares of Twenty-First Century Fox ended the day down $2.19, or 6.22%, to $33.00... Shares of Apple (AAPL) initially rose after announcing last night that it would collaborate with IBM (IBM) to provide mobile solutions for businesses. Goldman Sachs analyst Bill Shope wrote in a note to investors that the deal with IBM is clearly positive for Apple, as it validates the "unique enterprise capabilities" of iOS, which has a lack of fragmentation that makes it uniquely suited for organizations. BlackBerry (BBRY), which has a focus on mobile devices for business use, slid $1.33, or 11.77%, to $9.97 after the tech giants announced their new partnership. Apple closed down 54c, or 0.57%, to $94.78, though IBM (IBM), which reports after tomorrow's close, climbed $3.87, or 2.05%, to $192.36. MAJOR MOVERS: Among the notable gainers was Intel (INTC), which advanced $2.94, or 9.27%, to $34.65 after the semiconductor giant's second quarter results beat analysts' consensus estimates. Also higher was Tenet Healthcare (THC), which rallied $3.74, or 8.32%, to $48.71 after after another company in the hospital sector, HCA Holdings (HCA), pre-announced stronger than expected second quarter results. For its part, HCA rose $5.78, or 10.47%, to $60.99 after providing better than expected Q2 guidance and increasing its fiscal year outlook. Among the noteworthy losers was Yahoo (YHOO), which fell $1.82, or 5.11%, to $33.79 after the company's second quarter results fell short of analysts' consensus estimates. The company also said it will lower the amount of stock it will sell in Alibaba's initial public offering to 140M shares and that it plans to return "at least half" of its after-tax proceeds from the stake sale to its shareholders. Also lower were shares of Ross Stores (ROST), which fell $3.12, or 4.78%, to $62.15 after Sterne Agee downgraded its stock to Neutral from Buy and cut its price target for shares to $68 from $81, citing negative traffic trends and low visibility. INDEXES: The Dow rose 77.52, or 0.45%, to 17,138.20, the Nasdaq gained 9.58, or 0.22%, to 4,425.97, and the S&P 500 advanced 8.29, or 0.42%, to 1,981.57.
16:00 EDTINTCOptions Update; July 16, 2014
iPath S&P 500 VIX Short-Term Futures down 70c to 27.25. Option volume leaders: AAPL FB GOOG AMZN TWTR TSLA C HPQ TWX INTC AMZN according to Track Data.
12:26 EDTINTCOn The Fly: Midday Wrap
Subscribe for More Information
11:29 EDTINTCIntel hits 52-week high after results beat estimates
Subscribe for More Information
10:36 EDTCOV, MDTTreasury calls on Congress to halt inversion deals
Subscribe for More Information
10:00 EDTINTCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:23 EDTINTCOn The Fly: Pre-market Movers
HIGHER: Time Warner (TWX), up 15% after company confirmed that it rejected an $80B takeover offer from 21st Century Fox (FOX, FOXA), as had been reported earlier this morning... Apple (AAPL), up 2% after announcing an enterprise mobile partnership with IBM (IBM), which is also up 2%... International Game (IGT), up 9.5% after agreeing to be acquired by GTECH for $4.7B in cash and stock... FireEye (FEYE), up 5% after shares upgraded at Goldman... Precision Drilling (PDS), up 4% after announcing strategic agreement with Schlumberger (SLB), upgraded at Deutsche Bank... Mellanox (MLNX), up 4.7% following upgrade at Jefferies. UP AFTER EARNINGS: Intel (INTC), up 5.4%... HCA Holdings (HCA), up 6%... Textron (TXT), up 3.2%... Abbott (ABT), up 1%. DOWN AFTER EARNINGS: PNC Financial (PNC), down 2.5%... MGIC Investment (MTG), down 3.6%. LOWER: Yahoo (YHOO), down 3% after downgraded at CRT Capital following second quarter earnings report... Ares Capital (ARCC), down 2.5% after filing to sell 11.85M shares of common stock... Nationstar (NSM), down 2.4% after downgraded at Wells Fargo... Walter Investment (WAC), which was also downgraded at Wells Fargo, down 1.6%.
08:55 EDTJNJJohnson & Johnson pullback a buying opportunity, says Leerink
Leerink views the post-earnings pullback in shares of Johnson & Johnson as a buying opportunity. The firm expects "several" more quarters of outperformance and raised its price target for the stock to $115 from $110. It keeps an Outperform rating on J&J.
08:05 EDTINTCHP has positive read through from Intel results, says Pacific Crest
Pacific Crest has an upward bias on its estimates for HP (HPQ) following Intel's (INTC) positive comments on the PC market. The firm thinks that HP's stock could jump another 20% if enterprise PC fundamentals continue to improve. It keeps an Outperform rating on HP.
07:59 EDTCOV, MDTTreasury Secretary urges Congress to take action on tax inversions
Subscribe for More Information
07:47 EDTINTCIntel price target raised to $50 from $40 at Drexel Hamilton
Subscribe for More Information
07:39 EDTINTCIntel comments bode well for Mellanox, says Macquarie
Intel (INTC) said on its earnings call that the Haswell-EP Xeon E5 high-performance CPU built on the Grantley platform is already being shipped in pre-production quantities and is on track for a CYQ3 launch. Macquarie said Intel's commentary is a positive for the HPC market and Mellanox (MLNX) should see corresponding demand. Shares are Outperform rated with a $52 price target.
07:33 EDTINTCIntel price target raised to $45 from $40 at Jefferies
Subscribe for More Information
07:25 EDTJNJJohnson & Johnson should be bought on pullbacks, says RBC Capital
RBC Capital believes that Johnson & Johnson reported strong Q2 results, and the company raised its estimates for the company. The firm continues to recommend buying the stock on pullbacks.
07:18 EDTMDTScoliosis Research Society to hold annual meeting
Subscribe for More Information
07:17 EDTINTCIntel facing headwinds, says RBC Capital
After Intel reported stronger than expected results, RBC Capital thinks the company will be burdened by start-up costs in Q4 and 1Q15. The firm thinks there is a risk that the company's gross margins will drop and it keeps a Sector Perform rating on the shares.
07:06 EDTINTCIntel price target raised to $36 from $31 at Stifel
Stifel increased its price target on Intel after the company reported stronger than expected results for its June quarter and provided guidance for its September quarter that the firm views favorably. Stifel keeps a Buy rating on the shares.
07:01 EDTINTCIntel price target raised to $40 from $35 at Deutsche Bank
Subscribe for More Information
07:00 EDTINTCIntel price target raised to $40 from $35 at Credit Suisse
Subscribe for More Information
06:08 EDTINTCIntel moving 360 employees from Israel to Ireland, Globes reports
Subscribe for More Information
06:06 EDTINTCIntel upgraded to Buy from Neutral at B. Riley
Subscribe for More Information
06:04 EDTINTCIntel upgraded to Buy from Neutral at UBS
Subscribe for More Information
05:55 EDTINTCIntel price target raised to $37 from $31 at Piper Jaffray
Piper Jaffray raised its price target for Intel shares to $37 saying the company's momentum continues following its Q2 report. Piper keeps an Overweight rating on the stock.
July 15, 2014
18:29 EDTINTCOn The Fly: After Hours Movers
UP AFTER EARNINGS: Intel (INTC), up 4.1% after reporting second quarter results... AMD (AMD), up 1.6% after Intel reported quarterly results... Cintas (CTAS), up 1.6% after reporting fourth quarter results and fiscal 2015 guidance. ALSO HIGHER: IBM (IBM), up 1.8% after announcing an enterprise mobile partnership with Apple (AAPL), which is up 1.5%. DOWN AFTER EARNINGS: Yahoo! (YHOO), down 2.3% after reversing direction during the company's second quarter earnings conference call. ALSO LOWER: BlackBerry (BBRY), down 3.4% following IBM and Apple partnership announcement.
18:05 EDTINTCIntel says consumer remains challenging, soft
Subscribe for More Information
16:40 EDTJNJOn The Fly: Closing Wrap
Subscribe for More Information
16:31 EDTINTCIntel CFO says company strategy 'played out nicely' in first half
Says data center business extremely strong. Says still seeing soft consumer. Says on the cusp of a PC refresh cycle. Says goal is to keep long-term margins in 55%-65% range. Says needs to push costs down, battery life up. Stacy Smith is speaking on CNBC.
16:22 EDTINTCIntel announces increase of $20B to share repurchase plan
Intel announced that it intends to return more cash to shareholders by lowering its cash balance further through increased share repurchases. The board of directors authorized an increase of $20B to its share repurchase program and the company is forecasting share repurchases of approximately $4B in the third quarter, with additional share repurchases in the fourth quarter. Over the last decade Intel has returned almost $90B to shareholders through dividends and share repurchases.
16:15 EDTINTCIntel targets $4B for share repurchases in Q3
16:12 EDTINTCIntel up about 4% following better than expected Q2 results
Subscribe for More Information
16:10 EDTINTCIntel reports Q2 PC Client Group revenue $8.7B, up 9% sequentially, up 6% YoY
Subscribe for More Information
16:07 EDTINTCIntel says on track to meet 40M unit tablet goal
Subscribe for More Information
16:06 EDTINTCIntel reports Q2 gross margin 64.5%
16:06 EDTINTCIntel sees FY14 revenue growth approximately 5%, consensus $54.55B
Subscribe for More Information
16:04 EDTINTCIntel sees Q3 revenue $14.4B, plus or minus $500M, consensus $14.02B
Sees Q3 gross margin 66%, plus or minus a couple of percentage points.
16:03 EDTINTCIntel reports Q2 EPS 55c, consensus 52c
Subscribe for More Information
15:27 EDTINTCNotable companies reporting after market close
Subscribe for More Information
12:55 EDTINTCEarnings Preview: Intel up over 12% since pre-announcement
Intel (INTC) is expected to report second quarter earnings after the close on Tuesday, July 15, with a conference call scheduled for 5:00 pm ET. Intel is a global semiconductor manufacturer and a member of the Dow Jones Industrial Average. EXPECTATIONS: Analysts are looking for earnings per share of 52c on revenue of $13.69B. The consensus range is 45c-55c for EPS on revenue of $13.0B-$14.0B, according to First Call. Along with its first quarter report, Intel said it saw Q2 revenue of $13B, plus or minus $500M, compared to consensus at that time of $12.96B. Intel said then that it had expected its fiscal year 2014 revenue to be approximately flat, compared to consensus at that time of $53.15B. Subsequently, on June 12, Intel raised its Q2 revenue forecast to be $13.7B, plus or minus $300M, citing stronger than expected demand for business PCs. Intel added that it now expects some revenue growth for the year and that its full-year gross margin percentage is now expected to be in the upper half of the previous range of 61%, plus or minus a few percentage points, driven mostly by expected improvements in unit cost and volume. LAST QUARTER: Intel reported Q1 EPS of 38c, compared to consensus expectations at that time of 37c. The company's revenue of $12.8B was generally in-line with the consensus forecast. For the quarter, the company's gross margin came in at 59.7%. STREET RESEARCH: On the day after Intel made its positive pre-announcement, its stock was upgraded by several research firms. At that time, Morgan Stanley upgraded the shares to Equal Weight from Underweight, Roth Capital raised its rating to Buy from Neutral, and Drexel Hamilton upped its rating to Buy from Hold. Several firms also increased their price targets on Intel, with Jefferies raising its price target for Intel to $40 from $35 and Pacific Crest taking its target up to $35 from $32. Last night, coverage of Intel was initiated at Imperial Capital, which placed an Outperform rating and $37 target on the stock. NEWS: After eight quarters of declining shipments, worldwide PC shipments experienced flat growth in the second quarter of 2014, Gartner reported recently. Worldwide PC shipments totaled 75.8M units in the quarter, a 0.1% increase from the same quarter of 2013, according to Gartner. Another research firm, International Data Corporation, estimated that worldwide PC shipments totaled 74.4M units in the second quarter, marking a year-on-year decline of 1.7%. In company specific news, a July 9 report from MacRumors, citing Chinese site VR Zone, claimed that Intel has decided to further postpone the shipping of its line of 14-nanometer Broadwell chips, which are anticipated to be included in future versions of the Apple's (AAPL) MacBook Air, Retina MacBook Pro, and iMac. A report two days later from DigiTimes said that Intel is set to unveil its 14nm processors and 10nm wafers at its Developer Forum in San Francisco, citing sources from the upstream supply chain. According to the report, Intel will release the 14nm Core M-series processors in Q4 and 14nm Broadwell-based processors in January 2015. In June, The Wall Street Journal reported that Intel announced plans to package its standard server processors alongside a different class of programmable chip in a combination that includes an FPGA, or field programmable gate array. The Journal noted that FPGAs have been sold for years by Xilinx (XLNX) and Altera (ALTR), but that the general manager of Intelís data center group, Diane Bryant, declined to disclose Intelís partner on the latest effort or when the resulting products would hit the market. PRICE ACTION: Since the day after its earnings pre-announcement, Intel shares have risen over 12% and its stock is up more than 17% over the last three months. In afternoon trading ahead of tonight's report, Intel was trading near flat at $31.53.
12:21 EDTJNJOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday despite better than expected quarterly reports from two of the nation's largest financial institutions. Stock futures improved during the pre-market trading session, leading to a higher open for the broader market, following better than expected earnings reports from JP Morgan (JPM) and Goldman Sachs (GS). The earnings news also came alongside another huge M&A deal, as tobacco giants Reynolds American (RAI) and Lorillard (LO) confirmed plans to merge. However, the major averages weakened throughout the morning and fell into negative ground against the backdrop of Fed Chair Janet Yellen giving testimony on Capital Hill. In the Board of Governors' Monetary Policy Report, the central bank said valuation metrics in "some sectors" appear substantially stretched, "particularly those for smaller firms in the social media and biotechnology industries." ECONOMIC EVENTS: In the U.S., retail sales increased 0.2% in June compared to the month prior, making for the weakest reading since January and missing the consensus forecast for an increase of 0.6%. The Empire State manufacturing index climbed to a four-year high of 25.6 in July, beating expectations for a reading of 16.5. Import prices rose 0.1% in June, with export prices slipping 0.4%. Business inventories grew 0.5% in May, which was just below the 0.6% consensus growth expectation. In Europe, Germany's ZEW survey missed expectations, as both its Current Situation and Expectations reading were lower than forecast. COMPANY NEWS: Shares of JPMorgan advanced nearly 4% after the bank reported a profit of $1.46 a share, which included a legal expense of 13c a share, beating analysts' consensus forecast of $1.29. The earnings report comes after CEO Jamie Dimon recently disclosed that he has throat cancer. During the company's conference call, Dimon said he was "feeling great," that doctors had found no evidence of cancer anywhere except in the location where it had originally been detected, and that his prognosis for recovery is "excellent"... Also in the large-cap bank sector, Goldman Sachs' headline earnings and revenue similarly beat expectations. The firm, which said it ranks first in worldwide announced and completed mergers and acquisitions for the year-to-date, advanced about 1% following its report... Along with JPMorgan in the Dow Jones Industrial Average, Johnson & Johnson (JNJ) reported quarterly sales and profits that beat expectations and the healthcare conglomerate raised its fiscal year EPS view to $5.85-$5.92 from $5.75-$5.85. However, its increased outlook range still fell short of the $5.90 per share consensus forecast that analysts had prior to its report... Reynolds American confirmed news that has been speculated for many weeks, announcing that it will acquire peer Lorillard in a cash-and-stock transaction currently valued at $68.88 per Lorillard share, or a total of $27.4B, including the assumption of net debt. Shares of both fell afterward, with Lorillard down 8% to trade near $61.75 at midday and Reynolds slipping 5%. MAJOR MOVERS: Among the notable gainers was small-cap pharma biotechnology research company Codexis (CDXS), which surged nearly 50% after announcing a collaboration and license agreement with GlaxoSmithKline (GSK). Among the noteworthy losers was Aaron's (AAN), which is engaged in the lease ownership and retail sale of a variety of consumer products. Its stock fell over 6% after the company lowered its second quarter outlook, citing lower than expected performance of its core business as the reason for the revision. INDEXES: Near midday, the Dow was down 33.45, or 0.2%, to 17,021.97, the Nasdaq was down 40.48, or 0.91%, to 4,399.94, and the S&P 500 was down 9.24, or 0.47%, to 1,967.86.
10:05 EDTJNJJohnson & Johnson says committed to diabetes space
Subscribe for More Information
10:00 EDTINTCOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:50 EDTJNJJohnson & Johnson sees competition in Hepatitis products a headwind in 2015
Subscribe for More Information
09:36 EDTJNJJohnson & Johnson sees FY14 pre-tax op. margin improving over FY13
Subscribe for More Information
09:30 EDTJNJJohnson & Johnson says will buy back shares with net gain from OCD divestiture
Subscribe for More Information
09:28 EDTJNJJohnson & Johnson sees 2014 sales $74.5B-$75.3B, consensus $74.91B
Subscribe for More Information
08:54 EDTJNJJ&J CEO says confident about long term growth prospects of healthcare market
Subscribe for More Information
08:25 EDTJNJJohnson & Johnson says innovation sustaining long-term growth
Says MD&D progressing well towards 30 major filings by 2017. In Pharmaceuticals, sees 10 new products and 25 significant line extensions planned by 2017. Sees ~4.5% CAGR expected for WW prescription drug sales through 2017, despite potential headwinds. Comments from slides that will be presented on the Q2 earnings conference call.
07:49 EDTJNJJohnson & Johnson reports Q2 Worldwide Pharmaceutical sales of $8.5B
Subscribe for More Information
07:48 EDTJNJJohnson & Johnson raises FY14 EPS to $5.85-$5.92 from $5.75-$5.85
Subscribe for More Information
07:47 EDTJNJJohnson & Johnson reports Q2 Domestic sales up 14.9% to $9.13B
Subscribe for More Information
07:46 EDTJNJJohnson & Johnson reports Q2 EPS excluding items $1.66, consensus $1.55
Subscribe for More Information
07:33 EDTINTCIntel July 31.5 straddle priced for 3% move into Q2
Subscribe for More Information
07:23 EDTINTCFortune to hold a conference
Subscribe for More Information
July 14, 2014
19:19 EDTBSXBoston Scientific receives CE Mark for 25 mm Lotus Valve System
Subscribe for More Information
16:41 EDTINTCIntel initiated with an Outperform at Imperial Capital
Subscribe for More Information
15:24 EDTJNJNotable companies reporting before tomorrow's open
Subscribe for More Information
15:19 EDTJNJ Johnson & Johnson July 105 straddle priced for 1.6% move into Q2
14:27 EDTJNJEarnings Preview: J&J pharmaceutical sales expected to drive Q2
Johnson & Johnson (JNJ) is scheduled to report second quarter earnings before the market open on Tuesday, July 15, with a conference call scheduled for 8:30 am ET. Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. EXPECTATIONS: Analysts are looking for earnings per share of $1.55 on revenue of $18.94B, according to First Call. The consensus range for EPS is $1.45-$1.61 on revenue of $18.55B-$19.30B. LAST QUARTER: Johnson & Johnson reported first quarter EPS of $1.54 against estimates of $1.48 on revenue of $18.1B against estimates of $18B. The drug maker raised its fiscal year EPS view to $5.80-$5.90 against a consensus estimate of $5.83. J&J noted a 3.2% decrease in worldwide consumer sales in Q1 but saw a 10.8% increase in worldwide pharmaceutical sales. Primary contributors to operational sales growth in Q1 pharmaceutical sales were Stelara, Invega, Sustenna/Xeplion, Prezista, Velcade and sales of new products. Pharmaceutical sales results were negatively impacted by loss of exclusivity for Aciphex, a proton pump inhibitor for gastrointestinal disorders and Concerta for the treatment of attention deficit hyperactivity disorder. STREET RESEARCH: On July 14, RBC Capital raised its Q2 estimates for Johnson & Johnson to reflect the firm's outlook for higher pharmaceutical sales by the company. The firm raised its price target on the shares to $110 from $106 and kept an Outperform rating on the stock. PRICE ACTION: Shares of Johnson & Johnson are up approximately 8.5% since its last earnings report, and are trading near flat in afternoon trading.
13:02 EDTINTCIntel technical comments ahead of earnings
Subscribe for More Information
12:24 EDTJNJJohnson & Johnson technical notes before earnings
The company is scheduled to report before market open on July 15th. The shares in the prior three months have risen by more than 8%, anticipating positive news for the current and forthcoming quarters. At the current price of $105.39, the only remaining established resistance on the daily chart is at the life high of $106.74. If the news and guidance is better than expected, a run to $110, or $115 at an extreme, would be possible. If the news fails to meet expectations or guidance is weak, support would be at $102.70, the 50-day moving average. A break below this uptrend support proxy would be a sell signal in many technical trading systems and would break an uptrend in place since early March of this year. On a sliding scale of increasingly weaker news, supports would next be at $99.96, and then at $96.87.
10:00 EDTCOVOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:14 EDTINTCSemiconductor top picks at Topeka
Topeka's anticipates strong unit growth in the smartphone, tablet and wearable end markets and recommends exposure to large/mid cap growth names Intel (INTC), Skyworks (SWKS), Atmel and (ATML), small cap growth name, Rambus (RMBS), and value names Freescale (FSL), Spansion (CODE) and Silicon Motion (SIMO).
09:07 EDTINTCMellanox Q3 guidance likely to be conservative, says Janney Capital
Janney Capital said it expects Mellanox' (MLNX) Q2 revenue to be in-line and for its Q3 guidance to be conservative, as the firm believes the High Performance Computing market has temporarily slowed ahead of Intel's (INTC) release of its Grantley processors. However, the firm thinks that HPC will recover soon and it maintains its Buy rating and $57 fair value estimate on Mellanox.
09:02 EDTBSXBoston Scientific receives CE mark for Ranger drug-coated balloon
Boston Scientific has received CE Mark for the Ranger Paclitaxel-Coated PTA Balloon Catheter. The technology is now in full European market launch. The Balloon provides physicians with an additional option to treat peripheral artery disease, delivering an anti-stenotic drug to diseased vascular tissue while leaving no permanent implant behind.
08:52 EDTINTCIntel volatility increases into Q2 and outlook
Intel July call option implied volatility is at 27, August is at 20, October is at 18; compared to its 26-week average of 19 according to Track Data, suggesting non-directional price movement into the expected release of Q2 on July 15.
08:34 EDTINTCPC market stability could be short-lived, Reuters says
Subscribe for More Information
08:30 EDTJNJJohnson & Johnson should be bought on any weakness, says RBC Capital
Subscribe for More Information
07:12 EDTMDT, COVCovidien downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information
06:31 EDTCOVCovidien downgraded to Neutral from Overweight at Piper Jaffray
July 12, 2014
18:33 EDTINTCIntel looks to Chinese unbranded makers to boost tablet presence, WSJ says
Subscribe for More Information
July 11, 2014
07:36 EDTJNJJohnson & Johnson Q2 EPS likely to exceed expectations, says Bernstein
Subscribe for More Information
06:06 EDTINTCIntel to unveil 14nm processors, 10nm wafers at IDF in September, DigiTimes says
Subscribe for More Information
July 10, 2014
08:02 EDTVRTXVertex announces retirement of Chief Scientific Officer Mueller
Subscribe for More Information
08:02 EDTMDTCryoLife appoints Pat Mackin as President and CEO effective September 2
Mackin is expected to be appointed to the company's board after his employment begins. Steven Anderson will continue to serve CryoLife (CRY) as its President and Chief Executive Officer until Mackin's employment begins and then continue as its Executive Chairman. Mackin joins CryoLife from Medtronic (MDT), where he most recently served as President of Cardiac Rhythm Disease Management.
July 9, 2014
10:20 EDTINTCReport says Intel delaying Broadwell chip shipment, MacRumors says
Intel (INTC) has decided to further postpone the shipping of its line of 14-nanometer Broadwell chips, which are anticipated to be included in future versions of the Apple's (AAPL) MacBook Air, Retina MacBook Pro, and iMac, according to MacRumors, citing a report on Chinese site VR Zone. Reference Link
06:34 EDTINTCFake document hits federal court in hiring case against tech giants, WSJ says
Subscribe for More Information
July 8, 2014
10:28 EDTBSXOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: A.O. Smith (AOS) initiated with an Outperform at Northland... Abengoa Yield (ABY) initiated with a Buy at BofA/Merrill... Aflac (AFL) initiated with a Buy at Drexel Hamilton... Aspen Aerogels (ASPN) initiated with a Buy at Canaccord... Boston Scientific (BSX) initiated with a Buy at CRT Capital... CSC (CSC) initiated with an Underweight at Morgan Stanley... Consumer Portfolio (CPSS) initiated with a Buy at Compass Point... Credit Acceptance (CACC) initiated with a Sell at Compass Point... Intuitive Surgical (ISRG) initiated with a Neutral at BTIG... Masimo (MASI) initiated with a Buy at BTIG... Memorial Resource (MRD) initiated with an Overweight at Barclays... MetLife (MET) initiated with a Buy at Drexel Hamilton... Mueller Water (MWA) initiated with a Market Perform at Northland... New York REIT (NYRT) initiated with a Market Perform at JMP Securities... NorthStar Asset Management (NSAM) initiated with a Market Perform at Keefe Bruyette... Ophthotech (OPHT) initiated with an Outperform at Oppenheimer... Performance Sports Group (PSG) initiated with an Outperform at Wedbush... Prudential (PRU) initiated with a Buy at Drexel Hamilton... RCS Capital (RCAP) initiated with a Neutral at BofA/Merrill... Santander Consumer (SC) initiated with a Neutral at Compass Point... Silicon Laboratories (SLAB) initiated with a Buy at MKM Partners... St. Jude Medical (STJ) initiated with a Buy at CRT Capital... Starwood Waypoint (SWAY) initiated with an Outperform at Keefe Bruyette... T-Mobile (TMUS) initiated with an Outperform at BMO Capital... TherapeuticsMD (TXMD) initiated with an Outperform at FBR Capital... Waddell & Reed (WDR) initiated with an Outperform at William Blair... Xerox (XRX) initiated with an Overweight at Morgan Stanley.
10:28 EDTVRTXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:04 EDTCOVCovidien added to short-term buy list at Deutsche Bank
Subscribe for More Information
07:04 EDTMDTMedtronic added to short-term buy list at Deutsche Bank
06:36 EDTBSXBoston Scientific initiated with a Buy at CRT Capital
Subscribe for More Information
06:29 EDTINTCSEMI predicts 21% increase in production equipment purchases in 2014, WSJ says
Subscribe for More Information
06:17 EDTINTCAtmel, Broadcom, Intel, Samsung announce collaboration
Atmel (ATML), Broadcom (BRCM), Dell, Intel (INTC), Samsung (SSNLF) and Wind River are joining forces to establish a new industry consortium focused on improving interoperability and defining the connectivity requirements for the billions of devices that will make up the Internet of Things. The Open Interconnect Consortium is focused on defining a common communications framework based on industry standard technologies to wirelessly connect and intelligently manage the flow of information among personal computing and emerging IoT devices, regardless of form factor, operating system or service provider. Member companies will contribute software and engineering resources to the development of a protocol specification, open source implementation, and a certification program, all with a view of accelerating the development of the IoT. The OIC specification will encompass a range of connectivity solutions, utilizing existing and emerging wireless standards and will be designed to be compatible with a variety of operating systems. Additional member companies are expected to join OIC in the coming months.
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use